Allyx Therapeutics key facts
as of Oct 2026- Developer of a therapeutic drug designed to reverse neurodegeneration.
- Allyx Therapeutics is valued at approximately $32.3M as of Oct 2026 (last reported valuation).
- It has raised $13.2M across 4 recorded rounds; the latest was Early Stage VC ($26.4M) in May 2026.
- Notable investors include National Institutes of Health, Connecticut Innovations, Bristol-Myers Squibb, Spring Mountain Capital, Elm Street Ventures — 10 tracked in total.
- Allyx Therapeutics has filed 2 Form Ds with the SEC since 2021, most recently Feb 2023 ($2.3M sold to 11 investors).
- Status: Privately Held (backing).
Allyx Therapeutics's last reported valuation, Feb 2023. Nothing priced has surfaced since.
- ·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
Allyx Therapeutics funding rounds
4 roundsWho backs Allyx Therapeutics
10Allyx Therapeutics valuation
Allyx Therapeutics's last reported valuation was $32.3 million in Feb 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Allyx Therapeutics raised?
Allyx Therapeutics has raised $13.2 million across 4 recorded rounds since 2021. The largest was a $7.6 million early-stage round in May 2021; the most recent was a $26.4 million early-stage round in May 2026.
Allyx Therapeutics has filed 2 Form Ds with the SEC since 2021, most recently in Feb 2023 ($2.3 million sold to 11 investors).
Allyx Therapeutics investors
10 investors are on record for Allyx Therapeutics, including National Institutes of Health, Connecticut Innovations, Bristol-Myers Squibb and Spring Mountain Capital. The early-stage round in May 2026 drew 32 investors.
About Allyx Therapeutics
Developer of a therapeutic drug designed to reverse neurodegeneration. The company's drug is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to administer a drug capable of delivering a disease-modifying approach and preserving cognition in patients.
- Sector
- Healthcare
- HQ
- New Haven, CT, United States
- Founded
- 2018
- Employees
- 5
- Website
- allyxthera.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.